Emergent Biosolutions Inc

EBS

Market Cap$276.16M

Close$

Compare Emergent Biosolutions

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Emergent Biosolutions Inc	-0.5	0%	-86%	0.2	1.4
Market Avg	54.3	1.27%	32%	-	1.3
Healthcare Avg	39.1	1.36%	17%	7.2	1.3

$13.00

Current Fair Value

146.6% upside

Undervalued by 146.6% based on the discounted cash flow analysis.

Share Statistics

Market cap	$276.16 Million
Enterprise Value	$1.10 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-11.0
Beta	0.0
Outstanding Shares	52,401,850
Avg 30 Day Volume	3,594,706

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-0.49
PEG	0.46
Price to Sales	0.24
Price to Book Ratio	0.44
Enterprise Value to Revenue	0.93
Enterprise Value to EBIT	-81.14
Enterprise Value to Net Income	-2
Total Debt to Enterprise	0.82
Debt to Equity	1.36

Revenue Sources

No data

ESG Score

No data

About Emergent Biosolutions Inc

CEO: Robert Kramer